The prolactin-inducible-protein (PIP): A regulatory molecule in adaptive and innate immunity ()
1. INTRODUCTION
The human Prolactin-inducible-protein (PIP)/Gross Cystic Disease Fluid Protein-15 (GCDFP-15) was first reported by Haagensen et al. [1] as an acidic protein found in abundance in gross cystic disease fluid of the breast. Independently, it was identified by Shiu and Iwasiow [2] as a glycoprotein secreted by human breast cancer cells in response to the lactogenic hormone prolactin [3,4] and was designated Prolactin-inducibleprotein (PIP). PIP has also been subsequently identified to be analogous to Glycoprotein-17 (gp17) [5], Secretory Actin-Binding Protein (SABP) [6], and Extraparotid Glycoprotein (EP-GP) [7].
The PIP gene is located on chromosome 7q32-36 and is composed of 4 exons [8]. Only one 900 base mRNA transcript has been identified [3]. The protein is comprised of 146 amino acids and there is a signal peptide present on the 28th residue [1]. PIP is synthesized as a precursor polypeptide of 12.5 kDa and subsequent to the removal of the signal peptide; its size is reduced to 11 kDa [9]. The secreted protein has 3 isoforms, 11 kDa, 14 kDa, and 16 kDa in size, with the 14 kDa isoform being the predominant peptide [9]. The 14 kDa and the 16 kDa proteins are glycosylated forms of the 11 kDa protein.
1.1. Expression and Secretion of PIP
In healthy individuals, PIP expression has been associated with normal apocrine cells of the body [10]. PIP is highly expressed in the major salivary glands, lacrimal glands and sweat glands, and the protein is found abundantly in the secretions from these tissues; saliva, tears and sweat [11]. PIP is secreted from glands of the axilla, perineum and eyelid (Molls gland). As well, PIP is found in the secretions of the ear canal, bronchial submucosa and seminal vesicles [1]. PIP has also been detected in bodily fluids such as breast milk, amniotic fluid and blood [3,12].
PIP is abnormally expressed under various disease conditions associated with apocrine cells. PIP is one of the major glycoproteins that constitutes the pathologic secretion of gross cystic disease fluid from the premenopausal disorder, gross cystic disease of the breast [10]. While its gene expression is difficult to detect in normal breast epithelium [12], PIP expression is readily detected in breast epithelium that has undergone benign apocrine metaplasia. These apocrine cells are easy to identify as they have a unique morphology as well as a granular acidophilic cytoplasm [12].
PIP is also readily detectable in breast carcinoma cells with apocrine epithelium. Cytosol from breast carcinoma samples has been shown to contain PIP in varying amounts [13], with the highest levels associated with more differentiated carcinomas, the intraductal cribriform and the comedo types [10]. PIP has been detected in as many as 93% of human breast tumor biopsies [14] and plasma levels of PIP have been shown to be useful in monitoring about 40 percent of patients with metastatic breast carcinomas [10]. Due to the coincident consistent presence of PIP in both benign apocrine metaplasia and its gene expression in most breast cancer cells, PIP is now an established marker for abnormal breast [12].
In both normal and diseased states, the expression of the PIP gene is shown to be regulated by many hormones and cytokines. For example, PIP is up-regulated by androgens, glucocorticoids, and progesterone [2] and has been shown to be influenced by the cytokines IL-4/IL-13 in breast tumors [15]. Such hormonal regulation of PIP is well documented in previous reviews [9,16].
1.2. Structure/Function of PIP
To date, the function of PIP has not yet been elucidated, but there are many lines of evidence which suggest that its role is multifunctional. PIP is primarily thought to play a role in immune regulation, inhibition of bacterial growth, fertility, prostate and breast tumor progression, and more recently, in the formation of enamel pellicle [17,18]. Many of these aspects of PIP’s possible function have already been well reviewed recently by Hassan et al. [16], and, except for its role in immunity, will not be covered in depth here.
The recent determination of the crystal structure of PIP [16] has provided important insights into a possible role in immunity. The crystalline structure has revealed an immunoglobulin fold composed of seven antiparallel beta-strands and seven loops [16]. The identification of the beta folds is consistent with the hypothetical model previously proposed by Caputo et al. [19] who used a homology modeling approach to elucidate a three-dimensional model of the PIP protein. At that time, these authors suggested that the possession of a common “all beta-fold” composition was characteristic of aspartic proteinases [20], and further proceeded to demonstrate that PIP was indeed an aspartic proteinase [19].
It has also been shown that PIP has an ability to bind to numerous immunoregulatory molecules such as the CD4 molecule on T cells, immunoglobulin G (IgG), actin, and zinc α2-glycoprotein (ZAG), as well as non-immunomodulatory molecules, fibronectin and enamel pellicle. Importantly, the beta fold in PIP is thought to play a major role in such interactions [16,21-24]. Furthermore, PIP has been shown to bind to the glycoprotein CD4 cluster, which is found on the surface of immune cells such as T helper cells, monocytes, macrophages, and dendritic cells. These cells all have crucial roles in maintaining the adaptive and innate immune system, controlling the spread of infections and invasion of incoming pathogens [25].
2. A ROLE FOR PIP IN INNATE IMMUNITY
2.1. Innate Immunity
The innate immune system, otherwise known as the natural or first line of defense, is present at birth and relies on receptors commonly found in body fluids, tissue cells or mobile hematopoietic cells to detect microbial pathogens [26]. The innate defense is quick but lacks specificity. Among the cells that bear innate immune receptors are macrophages, dendritic cells, mast cells, neutrophils, eosinophils and natural killer (NK) cells [27]. Components of the innate immune system are responsible for the initial pathogenic contact and use anatomical barriers such as surface epithelium and mucous membrane secretions to carry out designated functions. This system protects the host from pathogen entry by providing a physical barrier and producing molecules such as mucins and other microbicidal products that help prevent the entry, attachment, and growth of harmful agents [26]. There is also a phagocytic component to the innate immune system where macrophages and neutrophils are activated upon pathogen exposure, and with the help of opsonins and complement, engulf and destroy the pathogen [26]. It is also known that physiological and inflammatory barriers greatly assist in the innate defense system. Chemokines and interleukins such as interleukin-1 (IL-1), IL-6, IL-4, IL-5, and IL-13 are key regulators of leukocytes. They signal the leukocytic action of mast cells, eosinophils, basophils, NK cells and dendritic cells during an infection and help to aid in the body’s inflammatory response [26].
2.2. PIP Involvement in First Line Defense: Inhibition of Bacterial Colonization
Many salivary components have the ability to interact with bacterium which frequently inhabit the oral cavity and deter their expansion. This property makes saliva an integral part of the innate immune defense system. Molecules in saliva that contribute to this interaction include alpha-amylase, immunoglobulin A, mucins, proline-rich glycoprotein, histatins, and lysozyme [28]. PIP, which is found in saliva, can be listed among these molecules, and as such, is thought to play a role in the first line of immune defense against invading pathogens [4]. Schenkels et al. [28] demonstrated that PIP (EP-GP), which is secreted by the salivary glands [17] has the ability to bind in vitro and inhibit the growth of several bacterial strains including Gemella, Staphlococcus and Streptococcus.
Moreover, PIP is not only present in the oral cavity. PIP is found strategically located at several other ports of pathogen entry, predominately in mucosal-type tissues that produce secretions involved in the first line of innate immune defense [1]. In addition to saliva, PIP is also present in other body fluids, including tears, sweat, nasal mucus, and ear wax that are involved in the first line defense of the host [12]. Overall, PIP constitutes approximately 1% of the total proteins present in these secretions.
As well as binding oral bacteria, PIP has been shown to bind bacteria affiliated with the skin and ear canal. Using immunofluorescence strategies Schenkels et al. [28] showed PIP (EP-GP) bound to a number of bacterial strains including Streptococci, Staphylococci, and Gemella harvested from the skin and ear canal, demonstrating that the binding of PIP to these bacteria is highly specific. These studies suggest that PIP can play a major role in further inhibiting bacterial colonization of the human body.
3. A ROLE FOR PIP IN ADAPTIVE IMMUNITY
3.1. Adaptive Immunity
Adaptive immunity otherwise known as the acquired or specific immunity, relies on the expansion of lymphocytes that express highly diverse, clonally restricted antigen-specific receptors arising from rearrangements of gene segments encoded in specialized genetic loci [26]. The function of the adaptive immune response is to destroy invading pathogens and any toxins they produce. This system targets specifically foreign entities to prevent destruction of host defenses [29]. The key mediators in the adaptive response are white blood cells known as lymphocytes that produce two broad classes of responses [29]. The first is the antibody-mediated response that depends on B lymphocytes. Antibodies protect the host through a variety of mechanisms such as the neutralization of toxins, lysis of bacteria through complement activation, opsonization of bacteria to facilitate phagocytosis, and interference with adherence of bacteria/viruses to cell surfaces [25]. The other class of response is the cell-mediated response that depends on T lymphocytes [29]. T cell activation for subsequent effector functions is regulated by their interaction with dendritic cells, which are specialized antigen-presenting cells that are critically important for T cell recognition of antigens. Dendritic cells express toll-like receptors (TLR), which specifically recognize discrete pathogen associated molecular patterns. Ligation of TLRs on dendritic cells leads to their activation, the production of inflammatory cytokines such as IL-6, IL-12, tumor necrosis factor (TNF) and expression of co-stimulatory molecules [30].
Two major subsets of T cells are recognized, CD4+ T cells (also known as helper T cells) and CD8+ T cells (also known as cytotoxic T cells). CD4+ T cells produce IL-2, IL-4 and IL-5, which aid in the production of antibodies. IL-2 also helps to activate CD8+ cells to become fully functional cytotoxic cells equipped to kill virally infected, tumor, and allograft cells [25]. Both CD4+ and CD8+ T cells produce gamma interferon, which activates macrophages to produce pro-inflammatory cytokines and free radicals necessary for killing intracellular pathogens.
3.2. PIP Involvement in Adaptive Immunity
The binding and interaction of PIP to several components of the adaptive immune system has led to the speculation that it may be an important component of the adaptive immune system. Its interaction with some of these molecules, including the CD4 molecule on T cells, IgG, IL-4 and IL-13 as well as its inherent characteristic of an aspartyl protease are briefly summarized.
3.2.1. PIP-CD4 Interactions
CD4 acts as a signaling molecule during T cell activation and is a co-receptor for the interaction of T cell receptor (TCR) with the major histocompatibility complex class-II (MHC-ll) molecule on antigen-presenting cells [31]. CD4 is also the primary viral receptor for Human Immunodeficiency Virus-1 (HIV-1) [32,33] that allows viral entry into T-helper lymphocytes. The interaction of CD4 with the HIV-1 envelope glycoprotein gp120 mediates attachment and penetration of the virus into the cell [34]. Autiero et al. [35] showed that the interaction of PIP with the first domain of CD4 induces a conformational change that disrupts the binding of HIV retrovirus to CD4+ cells and the post-binding events that follow. Also, it is well established that HIV infection induces immunosuppression by causing a loss of CD4+ T cells and that the interaction of PIP with CD4 on the T cell, blocks the forced apoptotic pathway that would normally occur [36]. Thus, PIP has the ability to inhibit this process, helping to sustain the adaptive immune response of the host that would otherwise be disturbed by the sequential CD4/TCR triggering during a viral infection.
PIP has also been reported to bind to the D1-D2 region of CD4 with high affinity in human seminal plasma [35,37]. Human seminal plasma is known to have a wide array of effects on immune function. It is therefore possible that PIP interaction with CD4 may contribute to the immunosuppressive properties of human seminal plasma.
3.2.2. Stimulation of PIP Expression by IL-4/IL-13
It has been demonstrated that both IL-4 and IL-13 could act in breast cancer cells to regulate proliferation and protein expression [15]. Furthermore, NK cells isolated directly from the tumor site were shown to secrete an abundance of INF-γ and IL-4 when compared to the cells collected from the patient’s blood [38]. It has also been demonstrated that exposure of the breast cancer cell line, ZR-75, to IL-4 and IL-13, up-regulated PIP mRNA levels 5.5 and 6.0 fold, respectively [15]. Due to the observation that PIP binds to CD4 domains that interact with MHC-II molecules (that are involved in antigen recognition) [39], it is thus likely that the increase in PIP expression in response to IL-4 and IL-13 levels may modulate the activity of infiltrating CD4+ T cells [15], and thus contribute to the innate and adaptive immune response.
3.2.3. PIP Binding to IgG
PIP has also been shown to bind to the constant region of IgG [40]. It has been proposed that the binding of PIP to IgG influences anti-sperm antibodies (ASA) and fertility [16]. However when the level of PIP in the seminal plasma of fertile men was compared to those of infertile men, there was no difference regardless of the status of ASA [40]. Thus, the evidence to support such a hypothesis is still lacking.
3.2.4. Aspartyl Proteinase Activity of PIP
Caputo et al. [19] showed for the first time that PIP was an aspartic protease. This was indeed an important observation as other aspartic proteases such as cathepsins D and E are known to play a role in the intracellular protein degradation in endosomes and lysosomes [41] and in so doing aspartic proteases are thought to serve an immune function. Once a pathogen is engulfed by a leukocyte, it is stored in the phagosome vesicle where it is later degraded. Using an in vitro assay it has been demonstrated that PIP could degrade fibronectin [19]. Indeed many molecules involved in the adaptive immune response start their signal transduction pathway on the cell surface. For instance, signals which originate from outside the cell (outside-in signals) generated by α1β2 integrins can act as a co-stimulus for the T cell receptor/CD3 complex, resulting in an IL-2 dependent proliferation of T cells [42]. Fibronectin has also been shown to specifically synergize with anti-CD3 antibody in the activation of the CD4 molecule [43], which plays a crucial role as a co-receptor that assists the T cell in communication with antigen presenting cells. Since fibronectin plays a central role in cell adhesion, the interaction of PIP with fibronectin may impact this pathway, resulting in a failure of the adaptive immune response to function appropriately, and thus could have detrimental effects on immune function.
The ability of PIP to degrade fibronectin may have yet other implications. For example, it has been demonstrated that many breast carcinomas have the ability to produce and secrete PIP [44]. PIP is usually weakly expressed or absent in normal breast tissue [19]. The discovery that PIP is an aspartyl protease suggests that it could play a role in the lytic processes associated with invasive breast cancer lesions [19]. This ability is common to other proteinases as well, such as matrix metalloproteinases [45] and secreted lysosomal enzymes [46]. Recently, Naderi et al., [47] showed that PIP mediates cell invasion and regulates integrin in breast cancer. Furthermore, secreted aspartyl proteinases are thought to contribute to the induction of an inflammatory host immune response as the addition of an aspartyl proteinase inhibitor was shown to strongly reduce the cytokine response to a C. albicans epithelial infection [48].
Thus, although definitive evidence showing a role for PIP in host immunity is lacking, its ability to potentially bind with several important host molecules including CD4, IgG, actin, zinc α2-glycoprotein (ZAG), fibronectin and enamel pellicle, suggests that it may have important biological functions [16,21-24,49]. However, despite these predicted functions, no study has clearly demonstrated the immunoregulatory role of PIP, particularly its role in modulating CD4+ T cells immune response in vitro or in vivo.
4. INSIGHTS GAINED FROM THE PIP KO MOUSE MODEL: SUPPORTING EVIDENCE FOR AN IMMUNOREGULATORY ROLE
To better understand the function of PIP, we generated a PIP knockout (KO) mouse model [50]. Mouse prolactin-inducible-protein (mPIP), also known as the mouse submaxillary gland protein (mSMGP), is a 14 kDa protein and is the murine homologue of human PIP [11,51]. mPIP also displays 51% sequence identity with human PIP [8].
In terms of tissue specific expression, mPIP displays a high level of similarity to its human counterpart. Like the human PIP, mPIP expression was found to be strategically associated with tissues located at several ports of entry. The mRNA is highly expressed in both sailvary and lacrimal glands. As well, mPIP is found abundantly in the secretions of these glands, namely saliva and tears [11,50]. Importantly, the activities of both the human and mouse protein bear much similarity with regards to function. We demonstrated that mPIP can specifically bind to several bacterial strains, both human and mouse, including some within the genus Streptococcus, which are known to inhabit the oral cavity [52]. We further demonstrated that the binding of mPIP to the bacteria was capable of promoting bacterial aggregation and in so doing, possibly inhibiting further proliferation [52]. Such studies provide further key evidence to suggest that one of the functions of mPIP may be in antibacterial activities related to host defense.
In light of such evidence, the PIP KO mouse model provides an excellent tool to further address PIP function. Gross findings reveal no overt phenotypic changes and the PIP KO mice appear to grow and develop normally. However, histological analyses revealed enlarged submandibular lymph nodes, lymphocytic aggregations within the prostate lobes, enlarged medulla within the thymus, and cardiac arteritis and peri-arteritis [50]. Ulcerative colitis and dense infiltration of neutrophils in mucosa and lamina propria, as well as monocytic and lymphocytic infiltration in the gut associated lymphoid tissues of the intestine were also evident [50]. Furthermore, functional analyses of gene expression showed sets of differentially expressed genes associated with cell death and survival, inflammation, immune response and cancer [50].
4.1. mPIP in Innate Immunity
As well, we found that, when compared to wild type (WT) controls, there were both quantitative and compositional differences in the oral flora of PIP KO mice. Bacteria belonging to several different genera were identified in the oral cavity of both WT and PIP KO mice. However, Streptococci represented a higher proportion of the oral bacteria that inhabited the mouth of the PIP KO mice, when compared to the WT mice. Interestingly, we also observed that certain bacteria genera such as Neisseria were notably absent from the oral cavity of the PIP KO mice. As well, Gram negative rods isolated from WT mice were absent in PIP KO mice [53]. These findings strongly suggest that mPIP plays a role in regulating the colonization of the oral flora.
4.2. Does PIP Play a Direct Role in Adaptive Immunity?
In a recent study (unpublished data), we carried out indepth immunophenotypic analyses of primary and secondary lymphoid organs in order to compare them to WT counterpart mice. Although we observed no difference in the single positive (CD4+CD8− and CD4−CD8+) and double negative (CD4−CD8−) populations in the thymus and, that the percentages of NK and B cells were comparable, we found that the PIP KO mice had significantly lower numbers of CD4+ cells in their spleen and lymph nodes.
We further addressed the contributions of PIP in T cell responses to model antigens and infectious agents. Bone marrow dendritic cells (BMDCs) from PIP KO mice showed significantly lower expression of co-stimulatory molecules and pro-inflammatory cytokine production upon stimulation with different TLR agonists. In addition, naïve CD4+ T cells from PIP KO mice exhibited significantly impaired T helper cell type 1 differentiation (IFN-γ production) in vitro and in vivo. Furthermore, PIP KO mice failed to control infection with Leishmania major as evidenced by progressive cutaneous lesion and inability to control parasite replication. Thus, our findings for the first time implicated PIP as an important CD4+ T cell modulatory protein that plays a critical role in effective cell-mediated immunity and resistance to an intracellular pathogen. On-going studies will further delineate the mechanisms through which PIP regulates T cell-mediated immunity in mice.
5. CONCLUSION
The PIP gene sequence is conserved across a broad range of species, suggesting that its retention may play a necessary role in the survival/fitness of a specie. To date, the function of this protein is still not clearly defined. However collectively, many studies indicate that the role of PIP is multifunctional. Moreover, recent studies from the PIP KO mouse model have provided strong supporting evidence to suggest that PIP plays a role in both an innate and adaptive immune host response to invading pathogens, and may be an important novel immunoregulatory molecule in host defense.
6. ACKNOWLEDGEMENTS
This work is supported by a grant from the Natural Sciences and Engineering Research Council of Canada (NSERC). The authors would like to acknowledge Anne Blanchard for reviewing and editing the manuscript.
NOTES